Indeed, the first review from Lunger et al. [32] reports that [225Ac]Ac-PSMA-617 could be a promising alternative for patients developing progression under [177Lu]Lu-PSMA-617 but would induce mostly permanent xerostomia. Here, FOLH1 is linked to xerostomia.